Concepedia

Zongxing Qiu

ZQ

Statistics

Publications

12

Citations

513

H-Index

11

Active since

2002

Affiliations

Roche (China)(Current)

WuXi AppTec (China)

La Roche College

Roche (United States)

Roche (Switzerland)

Zongxing Qiu is an author at Roche (China) specializing in drug discovery, drug design, and medicinal chemistry.

Publications per year

2002–2019

12

Publications

12

Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors

Zongxing Qiu, Xianfeng Lin, Mingwei Zhou et al. · Journal of Medicinal Chemistry · 2016 · 75 citations · Full text

, , +17

Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Benzyl derivatives with broad potency against resistant mutant viruses

D Kertesz, Christine Brotherton‐Pleiss, Minmin Yang et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 71 citations · Full text

, , +16

Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors

Zongxing Qiu, Bernd Kuhn, Johannes D. Aebi et al. · ACS Medicinal Chemistry Letters · 2016 · 67 citations · Full text

, , +16

Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors

Zongxing Qiu, Xianfeng Lin, Weixing Zhang et al. · Journal of Medicinal Chemistry · 2017 · 59 citations · Full text

, , +16

Inhibition of Influenza A Virus (H1N1) Fusion by Benzenesulfonamide Derivatives Targeting Viral Hemagglutinin

Yuhuan Li, Shaohua Li, Haodong Li et al. · PLoS ONE · 2011 · 50 citations · Full text

, , +16

1–5 of 12